Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E ... - Mark...

Google News

mynewsbot のブックマーク 2012/08/04 05:36

<blockquote class="hatena-bookmark-comment"><a class="comment-info" href="https://b.hatena.ne.jp/entry/104638706/comment/mynewsbot" data-user-id="mynewsbot" data-entry-url="https://b.hatena.ne.jp/entry/www.marketwatch.com/story/capstone-therapeutics-enters-into-a-joint-venture-for-the-development-of-apo-e-mimetic-peptide-aem-28-and-analogs-and-announces-conference-call-2012-08-03" data-original-href="http://www.marketwatch.com/story/capstone-therapeutics-enters-into-a-joint-venture-for-the-development-of-apo-e-mimetic-peptide-aem-28-and-analogs-and-announces-conference-call-2012-08-03" data-entry-favicon="https://cdn-ak2.favicon.st-hatena.com/64?url=http%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fcapstone-therapeutics-enters-into-a-joint-venture-for-the-development-of-apo-e-mimetic-peptide-aem-28-and-analogs-and-announces-conference-call-2012-08-03" data-user-icon="/users/mynewsbot/profile.png">Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E Mimetic Peptide AEM-28 and Analogs and Announces Conference Call - MarketWatch</a><ul class="comment-tag" style="list-style: none; margin: 0px;"><li style="float: left">[<a href="https://b.hatena.ne.jp/q/%22Google%20News%22">Google News</a>]</li></ul><br><p style="clear: left"> Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E ... - Mark...</p><a class="datetime" href="https://b.hatena.ne.jp/mynewsbot/20120804#bookmark-104638706"><span class="datetime-body">2012/08/04 05:36</span></a></blockquote><script src="https://b.st-hatena.com/js/comment-widget.js" charset="utf-8" async></script>

このブックマークにはスターがありません。
最初のスターをつけてみよう！

Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E Mimetic Peptide AEM-28 and Analogs and Announces Conference Call - MarketWatch

www.marketwatch.com2012/08/04

1 人がブックマーク・1 件のコメント

他のコメントを読む

＼コメントがサクサク読めるアプリです／

はてなブックマーク

Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E Mimetic Peptide AEM-28 and Analogs and Announces Conference Call - MarketWatch

はてなブックマーク

公式Twitter

はてなのサービス